The round was led by ARCH Venture Partners, with participation from new investor DFJ Growth and existing investors F-Prime, General Catalyst, GV, Lux Capital, Mubadala Capital, the American Cancer Society's BrightEdge Fund, and others, several of whom took super pro-rata positions.

本轮融资由ARCH Venture Partners领投，新投资者DFJ Growth以及现有投资者F-Prime、General Catalyst、GV、Lux Capital、Mubadala Capital、美国癌症协会的BrightEdge基金等参与，其中数家投资者获得了超比例份额。

Paradigm Health is rebuilding the clinical research ecosystem by creating a platform that enables equitable access to trials for all patients, while enhancing trial efficiency and reducing the barriers to participation for healthcare providers. Incubated by ARCH Venture Partners and backed by leading healthcare and life sciences investors, Paradigm Health aims to break down barriers across the trial ecosystem through one seamless infrastructure implemented at healthcare provider organizations, bringing potentially life-saving therapies to patients faster..

Paradigm Health正在通过创建一个平台来重建临床研究生态系统，该平台使所有患者都能公平地获得试验机会，同时提高试验效率并减少医疗保健提供者参与的障碍。在ARCH Venture Partners的孵化下，并由领先的医疗保健和生命科学投资者支持，Paradigm Health旨在通过在医疗机构实施的一个无缝基础设施，打破试验生态系统中的障碍，从而更快地将可能挽救生命的疗法带给患者。